Skip to main content
. 2016 Sep 3;2016(9):CD003384. doi: 10.1002/14651858.CD003384.pub3

1.3. Analysis.

1.3

Comparison 1 Topiramate vs placebo as monotherapy, Outcome 3 Acceptability with topiramate as monotherapy. Number of participants experiencing troublesome side effects of any nature (endpoint: 12 weeks).